Interaction of multipotent mesenchymal stromal and immune cells: Bidirectional effects

Cytotherapy - Tập 19 - Trang 1152-1166 - 2017
Elena Andreeva1, Polina Bobyleva1, Aleksandra Gornostaeva1, Ludmila Buravkova1
1Institute of Biomedical Problems, the Russian Academy of Sciences, Moscow, Russia

Tài liệu tham khảo

Crisan, 2008, A perivascular origin for mesenchymal stem cells in multiple human organs, Cell Stem Cell, 3, 301, 10.1016/j.stem.2008.07.003

Wang, 2016, Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials, J Biomed Sci, 23, 76, 10.1186/s12929-016-0289-5

Johnson, 2016, Mesenchymal stromal cells for immunoregulation after liver transplantation: the scene in 2016, Curr Opin Organ Transplant, 21, 541, 10.1097/MOT.0000000000000361

Hsuan, 2016, Mesenchymal stem cell-based treatments for stroke, neural trauma, and heat stroke, Brain Behav, 6, e00526, 10.1002/brb3.526

Peired, 2016, Mesenchymal stem cell-based therapy for kidney disease: a review of clinical evidence, Stem Cells Int, 2016, 4798639, 10.1155/2016/4798639

Nitkin, 2016, Concise review: mesenchymal stem cell therapy for pediatric disease: perspectives on success and potential improvements, Stem Cells Transl Med

Buravkova, 2010, Interaction of human mesenchymal stromal with immune cells, Hum Physiol, 36, 590, 10.1134/S0362119710050117

English, 2011, Allogeneic mesenchymal stem cells: agents of immune modulation, J Cell Biochem, 112, 1963, 10.1002/jcb.23119

Buravkova, 2009, Characteristics of human lipoaspirate-isolated mesenchymal stromal cells cultivated under a low oxygen tension, Cell Tissue Biol, 51, 23, 10.1134/S1990519X09010039

Grinakovskaya, 2009, Low level of O2 inhibits commitment of cultured mesenchymal stromal precursor cells from the adipose tissue in response to osteogenic stimuli, Bull Exp Biol Med, 147, 760, 10.1007/s10517-009-0612-1

Dos Santos, 2010, Ex vivo expansion of human mesenchymal stem cells: a more effective cell proliferation kinetics and metabolism under hypoxia, J Сell Рhysiol, 223, 27

Fehrer, 2007, Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan, Aging Cell, 6, 745, 10.1111/j.1474-9726.2007.00336.x

Di Nicola, 2002, Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli, Blood, 99, 3838, 10.1182/blood.V99.10.3838

Krampera, 2003, Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, 101, 3722, 10.1182/blood-2002-07-2104

Crop, 2011, Human mesenchymal stem cells are susceptible to lysis by CD8+ T-cells and NK cells, Cell Transplant, 20, 1547, 10.3727/096368910X564076

Aggarwal, 2005, Human mesenchymal stem cells modulate allogeneic immune cell responses, Blood, 105, 1815, 10.1182/blood-2004-04-1559

Maccario, 2005, Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype, Haematologica, 90, 516

Meisel, 2004, Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation, Blood, 103, 4619, 10.1182/blood-2003-11-3909

Nasef, 2007, Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells, Gene Expr, 13, 217

Crop, 2010, Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells, Clin Exp Immunol, 162, 474, 10.1111/j.1365-2249.2010.04256.x

Benvenuto, 2007, Human mesenchymal stem cells promote survival of T cells in a quiescent state, Stem Cells, 25, 1753, 10.1634/stemcells.2007-0068

Bartholomew, 2002, Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo, Exp Hematol, 30, 42, 10.1016/S0301-472X(01)00769-X

Prasad, 2011, Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study, Biol Blood Marrow Transplant, 17, 534, 10.1016/j.bbmt.2010.04.014

Lazarus, 2005, Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients, Biol Blood Marrow Transplant, 11, 389, 10.1016/j.bbmt.2005.02.001

Le Blanc, 2004, Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, 363, 1439, 10.1016/S0140-6736(04)16104-7

Zappia, 2005, Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy, Blood, 106, 1755, 10.1182/blood-2005-04-1496

Gornostaeva, 2011, Immunosuppressive effects of multipotent mesenchymal stromal cells in cultures with different O2 content in the medium, Bull Exp Biol Med, 151, 526, 10.1007/s10517-011-1372-2

Le Blanc, 2003, HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells, Exp Hematol, 31, 890, 10.1016/S0301-472X(03)00110-3

Li Pira, 2006, Human bone marrow stromal cells hamper specific interactions of CD4 and CD8 T lymphocytes with antigen-presenting cells, Hum Immunol, 67, 976, 10.1016/j.humimm.2006.08.298

Najar, 2009, Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6, Cytotherapy, 11, 570, 10.1080/14653240903079377

Ramasamy, 2008, The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function, Cell Immunol, 251, 131, 10.1016/j.cellimm.2008.04.009

Rasmusson, 2005, Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms, Exp Cell Res, 305, 33, 10.1016/j.yexcr.2004.12.013

Klyushnenkova, 2005, T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression, J Biomed Sci, 12, 47, 10.1007/s11373-004-8183-7

Le Blanc, 2003, Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex, Scand J Immunol, 57, 11, 10.1046/j.1365-3083.2003.01176.x

La Rocca, 2013, Human Wharton's jelly mesenchymal stem cells maintain the expression of key immunomodulatory molecules when subjected to osteogenic, adipogenic and chondrogenic differentiation in vitro: new perspectives for cellular therapy, Curr Stem Cell Res Ther, 8, 100, 10.2174/1574888X11308010012

Mukonoweshuro, 2014, Immunogenicity of undifferentiated and differentiated allogeneic mouse mesenchymal stem cells, J Tissue Eng, 5, 10.1177/2041731414534255

Lee, 2016, Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood, J Vet Sci, 17, 289, 10.4142/jvs.2016.17.3.289

Krampera, 2006, Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells, Stem Cells, 24, 386, 10.1634/stemcells.2005-0008

Le Blanc, 2004, Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes, Scand J Immunol, 60, 307, 10.1111/j.0300-9475.2004.01483.x

Magatti, 2008, Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities, Stem Cells, 26, 182, 10.1634/stemcells.2007-0491

Carrade Holt, 2014, Equine mesenchymal stem cells inhibit T cell proliferation through different mechanisms depending on tissue source, Stem Cells Dev, 23, 1258, 10.1089/scd.2013.0537

English, 2009, Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells, Clin Exp Immunol, 56, 149, 10.1111/j.1365-2249.2009.03874.x

Zhang, 2011, Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity, Invest Ophthalmol Vis Sci, 52, 3143, 10.1167/iovs.10-6334

Prevosto, 2007, Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction, Haematologica, 92, 881, 10.3324/haematol.11240

Glennie, 2005, Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells, Blood, 105, 2821, 10.1182/blood-2004-09-3696

Buravkova, 2011, Subpopulation composition and activation of T lymphocytes during coculturing with mesenchymal stromal cells in medium with different O(2) content, Bull Exp Biol Med, 151, 344, 10.1007/s10517-011-1326-8

Cappellesso-Fleury, 2010, Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells, J Clin Immunol, 30, 607, 10.1007/s10875-010-9415-4

Kronsteiner, 2011, Human mesenchymal stem cells from adipose tissue and amnion influence T-cells depending on stimulation method and presence of other immune cells, Stem Cells Dev, 20, 2115, 10.1089/scd.2011.0031

Saldanha-Araujo, 2012, Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-kB signalling, J Cell Mol Med, 16, 1232, 10.1111/j.1582-4934.2011.01391.x

Gornostaeva, 2016, Factors governing the immunosuppressive effects of multipotent mesenchymal stromal cells in vitro, Cytotechnology, 68, 565, 10.1007/s10616-015-9906-5

Augello, 2005, Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway, Eur J Immunol, 35, 1482, 10.1002/eji.200425405

Corcione, 2006, Human mesenchymal stem cells modulate B-cell functions, Blood, 107, 367, 10.1182/blood-2005-07-2657

Tabera, 2008, The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes, Haematologica, 93, 1301, 10.3324/haematol.12857

Sotiropoulou, 2006, Interactions between human mesenchymal stem cells and natural killer cells, Stem Cells, 24, 74, 10.1634/stemcells.2004-0359

Spaggiari, 2005, Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation, Blood, 107, 1484, 10.1182/blood-2005-07-2775

Poggi, 2005, Interaction between human NK cells and bone marrow stromal cells induces NK cell triggering: Role of NKp30 and NKG2D receptors, J Immunol, 175, 6352, 10.4049/jimmunol.175.10.6352

Djouad, 2007, Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism, Stem Cells, 25, 2025, 10.1634/stemcells.2006-0548

Zhang, 2004, Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells, Stem Cells Dev, 13, 263, 10.1089/154732804323099190

English, 2008, Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation, Immunol Lett, 115, 50, 10.1016/j.imlet.2007.10.002

Jiang, 2005, Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, Blood, 105, 4120, 10.1182/blood-2004-02-0586

Nauta, 2006, Mesenchymal stem cells inhibit generation and function of both CD34-derived and monocyte-derived dendritic cells, J Immunol, 177, 2080, 10.4049/jimmunol.177.4.2080

Gebler, 2012, The immunomodulatory capacity of mesenchymal stem cells, Trends Mol Med, 18, 128, 10.1016/j.molmed.2011.10.004

Najar, 2016, Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells, Cytotherapy, 18, 160, 10.1016/j.jcyt.2015.10.011

Haddad, 2014, Mechanisms of T-cell immunosuppression by mesenchymal stromal cells: what do we know so far?, Biomed Res Int, 2014, 216806, 10.1155/2014/216806

Nishizawa, 2016, Mechanisms of immunosuppression by mesenchymal stromal cells: a review with a focus on molecules, Biomed Res Clin Prac, 1, 82, 10.15761/BRCP.1000116

Tse, 2003, Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, Transplantation, 75, 389, 10.1097/01.TP.0000045055.63901.A9

DelaRosa, 2009, Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells, Tissue Eng Part A, 15, 2795, 10.1089/ten.tea.2008.0630

Yang, 2009, Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10, Exp Mol Med, 41, 315, 10.3858/emm.2009.41.5.035

Hemeda, 2010, Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells, Stem Cells Dev, 19, 693, 10.1089/scd.2009.0365

Ren, 2008, Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide, Cell Stem Cell, 2, 141, 10.1016/j.stem.2007.11.014

Sato, 2007, Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells, Blood, 109, 228, 10.1182/blood-2006-02-002246

Murakami, 2004, Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway, Prog Lipid Res, 43, 3, 10.1016/S0163-7827(03)00037-7

Hegyi, 2012, Activated T-cells and pro-inflammatory cytokines differentially regulate prostaglandin E2 secretion by mesenchymal stem cells, Biochem Biophys Res Commun, 419, 215, 10.1016/j.bbrc.2012.01.150

Nasef, 2007, Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G, Transplantation, 84, 231, 10.1097/01.tp.0000267918.07906.08

Selmani, 2008, Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells, Stem Cells, 26, 212, 10.1634/stemcells.2007-0554

Barondes, 1994, Galectins: a family of animal beta-galactoside-binding lectins, Cell, 76, 597, 10.1016/0092-8674(94)90498-7

Djouad, 2003, Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals, Blood, 102, 3837, 10.1182/blood-2003-04-1193

Xu, 2007, The role of IL-6 in inhibition of lymphocyte apoptosis by mesenchymal stem cells, Biochem Biophys Res Commun, 361, 745, 10.1016/j.bbrc.2007.07.052

Raffaghello, 2008, Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche, Stem Cells, 26, 151, 10.1634/stemcells.2007-0416

Zinöcker, 2012, Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase, Front Immunol, 3, 1, 10.3389/fimmu.2012.00062

Potian, 2003, Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens, J Immunol, 171, 3426, 10.4049/jimmunol.171.7.3426

Bobyleva, 2016, Tissue-related hypoxia attenuates proinflammatory effects of allogeneic PBMCs on adipose-derived stromal cells in vitro, Stem Cells Int, 2016, 4726267, 10.1155/2016/4726267

Ren, 2010, Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression, J Immunol, 184, 2321, 10.4049/jimmunol.0902023

Quaedackers, 2009, Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes, Eur J Immunol, 39, 3436, 10.1002/eji.200939584

Sheng, 2008, A critical role of IFN gamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1, Cell Res, 18, 846, 10.1038/cr.2008.80

Tipnis, 2010, Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO, Immunol Cell Biol, 88, 795, 10.1038/icb.2010.47

Anzalone, 2011, Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes, Stem Cell Rev Rep, 7, 342, 10.1007/s12015-010-9196-4

Xue, 2010, The negative cosignaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity, Stem Cells Dev, 19, 27, 10.1089/scd.2009.0076

Chen, 2004, Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity, Nat Rev Immunol, 4, 336, 10.1038/nri1349

Hofmeyer, 2008, The contrasting role of B7-H3, Proc Natl Acad Sci USA, 105, 10277, 10.1073/pnas.0805458105

Smith, 2014, B7-H4 as a potential target for immunotherapy for gynecologic cancers: a closer look, Gynecol Oncol, 134, 181, 10.1016/j.ygyno.2014.03.553

Chan, 2008, MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFNgamma challenge, Exp Hematol, 36, 1545, 10.1016/j.exphem.2008.06.008

Prasanna, 2010, Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially, PLoS ONE, 5, 10.1371/journal.pone.0009016

Prigione, 2009, Reciprocal interactions between human mesenchymal stem cells and gamma-delta T cells or invariant natural killer T cells, Stem Cells, 27, 693, 10.1634/stemcells.2008-0687

Ryan, 2007, Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells, Clin Exp Immunol, 149, 353, 10.1111/j.1365-2249.2007.03422.x

Lin, 2012, Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism, Cytotherapy, 14, 274, 10.3109/14653249.2011.635853

Croitoru-Lamoury, 2011, Interferon-γ regulates the proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO), PlosOne, 6, 10.1371/journal.pone.0014698

Buravkova, 2014, Mesenchymal stem cells and hypoxia: where are we?, Mitochondrion, 19, 105, 10.1016/j.mito.2014.07.005

Valencic, 2014, Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media, Stem Cell Res Ther, 5, 3, 10.1186/scrt392

Sivanathan, 2014, Interferon-gamma modification of mesenchymal stem cells: implications of autologous and allogeneic mesenchymal stem cell therapy in allotransplantation, Stem Cell Rev Rep, 10, 351, 10.1007/s12015-014-9495-2

Giuliani, 2014, IFNGamma priming protects fetal and embryonic MSC from NK cell-mediated killing and improves their immunosuppressive properties: role of activating and inhibitory receptors, J Cell Sci Ther, 5, 164

Li, 2012, Effects of cytokines and chemokines on migration of mesenchymal stem cells following spinal cord injury, Neural Regen Res, 7, 1106

Abarbanell, 2009, Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart, Ann Thorac Surg, 88, 1036, 10.1016/j.athoracsur.2009.02.093

Niu, 2015, Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence, Oncotarget, 6, 17938, 10.18632/oncotarget.4852

Zubkova, 2016, Regulation of adipose tissue stem cells angiogenic potential by tumor necrosis factor-alpha, J Cell Biochem, 117, 180, 10.1002/jcb.25263

Cao, 2015, Naringin rescued the TNF-α-induced inhibition of osteogenesis of bone marrow-derived mesenchymal stem cells by depressing the activation of NF-кB signaling pathway, Immunol Res, 62, 357, 10.1007/s12026-015-8665-x

Rodríguez, 2015, Effect of TGF-β1 stimulation on the secretome of human adipose-derived mesenchymal stromal cells, Stem Cells Transl Med, 4, 894, 10.5966/sctm.2015-0012

Czekanska, 2014, Enhancing inflammatory and chemotactic signals to regulate bone regeneration, Eur Cell Mater, 28, 320, 10.22203/eCM.v028a22

Liu, 2013, Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells, J Pineal Res, 55, 14, 10.1111/jpi.12045

Lejmi, 2015, Inflammatory chemokines MIP-1δ and MIP-3α are involved in the migration of multipotent mesenchymal stromal cells induced by hepatoma cells, Stem Cells Dev, 24, 1223, 10.1089/scd.2014.0176

Cuerquis, 2014, Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation, Cytotherapy, 16, 191, 10.1016/j.jcyt.2013.11.008

Chen, 2015, Pre-activation of mesenchymal stem cells with TNF-α, IL-1β and nitric oxide enhances its paracrine effects on radiation-induced intestinal injury, Sci Rep, 5, 8718, 10.1038/srep08718

Pourgholaminejad, 2016, The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells, Cytokine, 85, 51, 10.1016/j.cyto.2016.06.003

Li, 2015, Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function, J Biosci Bioeng, 121, 213, 10.1016/j.jbiosc.2015.05.017

Schmidt-Lucke, 2015, Cardiac migration of endogenous mesenchymal stromal cells in patients with inflammatory cardiomyopathy, Mediators Inflamm, 2015, 308185, 10.1155/2015/308185

Lederer, 1999, The effects of injury on the adaptive immune response, Shock, 11, 153, 10.1097/00024382-199903000-00001

Hoogduijn, 2010, The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy, Int Immunopharmacol, 10, 1496, 10.1016/j.intimp.2010.06.019

Murphy, 2013, Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine, Exp Mol Med, 45, e54, 10.1038/emm.2013.94

Sitkovsky, 2005, Regulation of immune cells by local tissue oxygen tension: HIF1alpha and adenosine receptors, Nat Rev Immunol, 5, 712, 10.1038/nri1685

Vanderkooi, 1991, Oxygen in mammalian tissue: methods of measurement and affinities of various reactions, Am J Physiol, 260, 1131, 10.1152/ajpcell.1991.260.6.C1131

Gordon, 1974, Parabarosis and experimental infections. 4. Effect of varying O2 tensions on chlamydial infection in mice and cell cultures, Aerosp Med, 45, 257

Naldini, 1999, Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation, J Cell Physiol, 181, 448, 10.1002/(SICI)1097-4652(199912)181:3<448::AID-JCP8>3.0.CO;2-F

Singh, 1977, Effects of high altitude stay on the incidence of common diseases in man, Int J Biometeorol, 21, 93, 10.1007/BF01553705

Caldwell, 2001, Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions, J Immunol, 167, 6140, 10.4049/jimmunol.167.11.6140

Panther, 2003, Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells, Blood, 101, 3985, 10.1182/blood-2002-07-2113

Román, 2002, CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function, J Exp Med, 196, 957, 10.1084/jem.20021052

Mikko, 2009, Hypoxia but not cigarette smoke modulates VEGF secretion from human T cells, Growth Factors, 27, 352, 10.3109/08977190903210863

Thông tin
Thông tin xuất bản

Cytotherapy

Tập 19

1152-1166

Thông tin tác giả